Search

The life science industry is all hands on deck in the race to develop vaccines, therapies and diagnostics in the fight against coronavirus. But while some prosper, many in the sector are forced to halt clinical trials and mothball labs

Action plan includes clinical trials funding and new research task force to share COVID-19 knowledge

The EU has mobilised fairly quickly, with a good mix of funding for research on the coronavirus pandemic, says Matthias Kleiner, president of the Leibniz Association

The COVID-19 pandemic provides a stark illustration of why we need effective tools for sharing health data in Europe, say four MEPs

The global pandemic is brutally exposing how reliant the EU – and the rest of the world – is on high quality research, collaboration and data sharing. These lessons must be applied in Horizon Europe  

The working relationship with the European Research Council’s star appointment was difficult from the off, but few imagined it would unravel so quickly